Showing results (51-60 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|March 19, 2022
Delivering specialised care to people ageing with HIV in the UK: experience and evolution of services from 2009 to 2019Ana Milinkovic, Branca Pereira, Maria Mazziteli, et al.
The Lancet. HIV|March 19, 2022
Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort studyJennifer S Lee, Elizabeth Humes, Brenna C Hogan, et al.
The Lancet. HIV|March 19, 2022
Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathwayGiada Sebastiani, Jovana Milic, Claudia Gioe, et al.
The Lancet. HIV|August 27, 2016
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial
The Lancet. HIV|August 27, 2016
Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling studyJessica B McGillen, Sarah-Jane Anderson, Mark R Dybul, et al.
The Lancet. HIV|May 15, 2017
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
The Lancet. HIV|September 24, 2016
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trialSteffen Leth, Mariane H Schleimann, Sara K Nissen, et al.
The Lancet. HIV|September 24, 2016
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort studyMonica Gandhi, David V Glidden, Kenneth Mayer, et al.
The Lancet. HIV|September 24, 2016
Paediatric HIV testing beyond the context of prevention of mother-to-child transmission: a systematic review and meta-analysisJennifer Cohn, Katherine Whitehouse, Julia Tuttle, et al.
The Lancet. HIV|April 13, 2018
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trialThomas A Rasmussen, James H McMahon, J Judy Chang, et al.
Pageof 79